The Section on Neurobiology, directed by Phillip Nelson, studies those
mechanisms by which input to the nervous system from the environment influences
nervous system development. In particular, we focus on the influence of
neural electrical and synaptic activity in modulating synaptic circuits
during development. We have identified some of the cell-biologic processes,
including protein kinase and neurotrophin action, that affect the strength
of synapses in vitro and in vivo.
Protein Kinase C and Protein Kinase A Mediate Activity-Dependent Modulation
of Synaptic Efficacy
Nelson, Jia, Li, Yang, Lanuza
Previous work with an in vitro synaptic system (see Figure 1) had
shown that protein kinase C (PKC) activation is necessary and sufficient
to produce a reduction in synaptic efficacy at the neuromuscular junction.
This was primarily a postsynaptic phenomenon that involved a loss of acetylocholine
receptors (AChR) from the high-density receptor clusters at the neuromuscular
synapse. Collaborative in vivo experiments show that PKC plays
a vital role in the intact animal. Transition from the polyneuronal to
mononeuronal innervation is blocked by PKC blockers and accelerated by
PKC activators during the middle stages of neuromuscular junction development.
PKC-independent processes become evident late in the maturation process.
We have used PKC theta knock-out animals in experiments both in vivo
and in vitro. Mice in which the theta isoform of PKC was knocked
out show a delay in the synapse elimination that occurs at the neuromuscular
junction, although loss of multiple innervation eventually does occur.
When synapses form in vitro between nerve and muscle from PKC theta
knock-out animals, stimulation of PKC no longer produces synapse loss.
When a PKC-activating phorbol ester such as PMA is placed in the center,
synaptic chamber of our three-compartment system, we see loss of synapses
as expected if PKC acted in the muscle. Similarly, a PKC blocker is effective
if applied only in the center, synaptic compartment. Also consistent with
a muscle locus of PKC action are the results of experiments in which PKC-deficient
muscle was combined with normal nerve in the side neuronal chambers. These
preparations showed a marked decrement in the synapse elimination produced
by PKC activation. More surprising were results with normal muscle and
PKC theta knock-out nerve. These preparations also showed a marked deficit
in PKC-induced synapse loss, entirely comparable to that shown with the
muscle knock-out/normal nerve combination. This suggests that presynaptic
PKC function must be combined with postsynaptic PKC to produce synapse
loss.
Figure 23
Illustration of the compartmental neuromuscular tissue
system.
a. Diagram of the teflon insert with stimulating electrodes and the neural
(side compartments) and myotube (center compartment) cultures. Cal 100
µm. b. Neurites coming from the two side compartments are stained
with an antibody against choline aceyltransferase to show the bilateral
cholinergic synaptic investment of a group of myotubes.
Protein kinase A (PKA) also probably has both pre- and
postsynaptic action. PKA mediates the stabilization and strengthening
of stimulated inputs, and we have shown that postsynaptic injection of
PKI, an inhibitor of PKA, in conjunction with electrical activation of
the synapse, results in a major loss of synaptic connectivity (Figure
24).
Figure 24
PKA activation prevents
stimulation-related synapse down-regulation. a. Left two bars are from
a control group with single inputs, stimulated for 2 h (n = 5). There
was no significant difference before and after stimulation (*p > 0.4).
Right two bars are for EPPs recorded in 10 experiments before and after
treatment with 1 µM H-89 in the center chamber plus electrical stimulation
for 2 h (n = 10, **p < 0.025). å before
the treatment, after the treatment. b. Intracellular recording of EPPs
were taken after PKI injection (5Hz. 30 msec ca. 1 nA for 30 minutes)
but before and after a 20-minute period without (left) or with (right)
5 Hz. neural stimulation. For both data sets, n = 4; p < 0.005. c.
Cyclic-AMP prevents the heterosynaptic loss of synapse strength produced
by unilateral stimulation of bilaterally innervated myotubes. EPPs were
measured before and after 2 h of stimulation with and without cAMP (2
mM) in the center chamber. For the unstimulated inputs, db cAMP produces
a significant block of EPP decrement (p < 0.004) å
stimulation only, no cAMP (n =10), _: stimulation with cAMP in the center
chamber, the cAMP was then washed out and the EPPs remeasured (n = 5).
d) Calcitonin gene-related peptide (CGRP) increases cellular cAMP level
and leads to the activation of PKA in muscle. CGRP (1µM) reduced
the functional synapse loss produced by unilateral electrical stimulation
(treatment and stimulation were for 20 h), control n =14, CGRP n =15,
p < 0.02.
When a PKA blocker, H-89, is applied to the side chamber
only, we also see a major activity-dependent loss of synapses that is
attributable to a decrease in the probability of release of neurotransmitter.
Such sensitivity to stimulation takes 20 to 30 minutes to develop, which
we interpret as the time for some PKA-dependent material to be transported
from the cell body to the synapse, where it is needed for maintaining
transmitter output.
Neurotrophic Action on Neuromuscular Synapse Structure
Yang, Nelson
We have examined the possibility that the Glia Derived Neurotrophic Factor
(GDNF) may have an effect on synapse stabilization. Others have shown
that GDNF released from muscle can affect presynaptic function. We have
tested whether there may be some effect of GDNF on muscle function, specifically
on the acetycholine receptor (AChR). We find that GDNF treatment of muscle,
even in the absence of nerve but also in innervated fibers, increases
the rate at which AChR is inserted into receptor clusters. GDNF treatment
does not affect the rate of loss of receptors from the clusters. We have
examined some of the cell biological mechanisms by which GDNF is coupled
to receptor disposition.
We feel that our results identify some of the critical postsynaptic events
mediating Hebbian plasticity; therefore, we will focus in the future on
possible presynaptic mechanisms.
|
PUBLICATIONS
- Kim
S, Nelson PG. Involvement of calpains in the destabilization of
the acetylcholine receptor clusters in rat myotubes. J Neurobiol 2000;42:22-32.
- Lanuza
MA, Garcia N, Santafe M, Nelson PG, Fenoll-Brunet MR, Tomas J. Pertussis
toxin-sensitive G-protein and protein kinase C activity are involved
in normal synapse elimination in the neonatal rat muscle. J Neurosci
Res 2001;63:330-340.
- Li
MX, Jia M, Jiang H, Dunlap V, Nelson PG. Opposing actions of protein
kinase A and C mediate Hebbian synaptic plasticity. Nat Neurosci 2001;4:871-872.
- Nelson
PG. Intrinsic dynamics in neuronal networks.I. Theory. J Neurophysiol
2000;83:808-827.
- Nelson
PG. Intrinsic dynamics in neuronal networks II. Experiment. J Neurophysiol
2000;83:828-835.
- Nelson
PG. Protein kinase C-mediated changes in synaptic efficacy at the
neuromuscular junction in vitro: the role of postlsynaptic acetylcholine
receptors. J Neurosci Res 2000;61:616-625.
- Nelson
PG. Thrombin action decreases acetylcholine receptor aggregate number
and stability in cultured mouse myotubes. Dev Brain Res 2000;122:119-123.
- Nelson
PG, McCune SK, Ades AM, Nelson KB. In: Lubec G, ed. Protein expression
in Down syndrome brain. 2001, in press.
- Rapoport J, Castellanos F, Gogate H, Janson K, Kohler S, Nelson PG.
Imaging normal and abnormal brain development-new perspectives for child
psychiatry. Aust N Z J Psychiatry 2001;35:272-281.
|